Literature DB >> 27106771

Personal, situational and organizational aspects that influence the impact of patient safety incidents: A qualitative study.

E Van Gerven1, D Deweer1, S D Scott2, M Panella3, M Euwema4, W Sermeus1, K Vanhaecht5.   

Abstract

OBJECTIVES: When a patient safety incident (PSI) occurs, not only the patient, but also the involved health professional can suffer. This study focused on this so-called "second victim" of a patient safety incident and aimed to examine: (1) experienced symptoms in the aftermath of a patient safety incident; (2) applied coping strategies; (3) the received versus needed support and (4) the aspects that influenced whether one becomes a second victim.
MATERIALS AND METHODS: Thirty-one in-depth interviews were performed with physicians, nurses and midwives who have been involved in a patient safety incident.
RESULTS: The symptoms were categorized under personal and professional impact. Both problem focused and emotion focused coping strategies were used in the aftermath of a PSI. Problem focused strategies such as performing a root cause analysis and the opportunity to learn from what happened were the most appreciated, but negative emotional responses such as repression and flight were common. Support from colleagues and supervisors who were involved in the same event, peer supporters or professional experts were the most needed. A few individuals described emotional support from the healthcare institution as unwanted. Rendered support was largely dependent on the organizational culture, a stigma remained among healthcare professionals to openly discuss patient safety incidents. Three aspects influenced the extent to which a healthcare professional became a second victim: personal, situational and organizational aspects.
CONCLUSION: These findings indicated that a multifactorial approach including individual and emotional support to second victims is crucial.
Copyright © 2016 SECA. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Comadronas; Enfermeras; Errores médicos; Medical errors; Médicos; Nurse midwives; Nurses; Patient safety; Physicians; Second victim; Segunda víctima; Seguridad del paciente

Mesh:

Year:  2016        PMID: 27106771     DOI: 10.1016/j.cali.2016.02.003

Source DB:  PubMed          Journal:  Rev Calid Asist        ISSN: 1134-282X


  5 in total

1.  Work-related adverse events leaving their mark: a cross-sectional study among Dutch gynecologists.

Authors:  Melanie A M Baas; Karel W F Scheepstra; Claire A I Stramrood; Ruth Evers; Lea M Dijksman; Maria G van Pampus
Journal:  BMC Psychiatry       Date:  2018-03-22       Impact factor: 3.630

2.  Duration of second victim symptoms in the aftermath of a patient safety incident and association with the level of patient harm: a cross-sectional study in the Netherlands.

Authors:  Kris Vanhaecht; Deborah Seys; Loes Schouten; Luk Bruyneel; Ellen Coeckelberghs; Massimiliano Panella; Gerda Zeeman
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

3.  Prevalence of second victims, risk factors and support strategies among young German physicians in internal medicine (SeViD-I survey).

Authors:  Reinhard Strametz; Peter Koch; Anja Vogelgesang; Amie Burbridge; Hannah Rösner; Miriam Abloescher; Wolfgang Huf; Brigitte Ettl; Matthias Raspe
Journal:  J Occup Med Toxicol       Date:  2021-03-29       Impact factor: 2.646

4.  [Primary care organization in pandemic times].

Authors:  Txema Coll Benejam; Jesús Palacio Lapuente; Rosa Añel Rodríguez; Montse Gens Barbera; Juan José Jurado Balbuena; Aina Perelló Bratescu
Journal:  Aten Primaria       Date:  2021-11-19       Impact factor: 1.137

5.  A Comparative Study Measuring the Difference of Healthcare Workers Reactions Among Those Involved in a Patent Safety Incident and Healthcare Professionals While Working During COVID-19.

Authors:  Deborah Seys; Evelien De Decker; Hadi Waelkens; Stephan Claes; Massimiliano Panella; Marina Danckaerts; Kris Vanhaecht
Journal:  J Patient Saf       Date:  2022-02-03       Impact factor: 2.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.